OVERVIEW

Journal CME/HeartRhythm Journal: August 2017 Vol. 14, Issue 8: Acute efficacy, safety, and long-term clinical outcomes using the second-generation cryoballoon for pulmonary vein isolation in patients with a left common pulmonary vein: A multicenter study is organized by Heart Rhythm Society (HRS). This Conference has been approved for a maximum of 1.0 AMA PRA Category 1 Credit™.

Release Date: 7/28/2017
Expiration Date: 7/26/2019

Target Audience:
This activity is designed for all professionals who participate in the care and management of heart rhythm disorders.

Overview:
Second-generation cryoballoon (CB2)-based pulmonary vein isolation (PVI) has demonstrated encouraging clinical results in the treatment of paroxysmal (PAF) and persistent atrial fibrillation (PersAF). However, the CB2 features a maximal diameter of 28 mm, and its adaptability to anatomic variations of the pulmonary veins (PVs) might be challenging. The purpose of this study was to assess the acute efficacy, safety, and long-term clinical results of CB2-based PVI in patients with a left common pulmonary vein (LCPV).

Learning Objectives:
• Evaluate the techniques used to perform a cryo-based pulmonary vein isolation (PVI) in patients with a left common pulmonary vein (LCPV).
• Demonstrate understanding of the techniques used to perform cryoballoon-based PVI in patients with a LCPV.
• Identify processes to reduce complications and promote safety measures for the patient during cryoballoon based ablation of atrial fibrillation.

Additional details will be posted as soon as they are available.